References
- Ferlay J, Soerjomataram I, Dikshit R, Parkin DM, Forman D, Bray F. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015; 136: E359-86. doi: 10.1002/ijc.29210
- Strojan P. [New approaches to radiotherapy of head and neck tumors]. [Slovenian]. Zdr Vestn 2010; 79: 339-53.
- Winquist E, Agbassi C, Meyers BM, Yoo J, Chan KKW. Systemic therapy in the curative treatment of head and neck squamous cell cancer: a systematic review. J Otolaryngol Head Neck Surg 2017; 46: 29. doi: 10.1186/s40463-017-0199-x
- Leeman JE, Li J, Pei X, Venigalla P, Zumsteg ZS, Katsoulakis E, et al. Patterns of treatment failure and postrecurrence outcomes among patients with locally advanced head and neck squamous cell carcinoma after chemoradiotherapy using modern radiation techniques. JAMA Oncol 2017; 3: 1487-94. doi: 10.1001/jamaoncol.2017.0973
- Pignon J-P, Maître A le, Maillard E, Bourhis J. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients. Radiother Oncol 2009; 92: 4-14. doi: 10.1016/j. radonc.2009.04.014
- Brizel DM, Prosnitz RG, Hunter S, Fisher SR, Clough RL, Downey MA, et al. Necessity for adjuvant neck dissection in setting of concurrent chemoradiation for advanced head-and-neck cancer. Int J Radiat Oncol 2004; 58: 141823. doi: 10.1016/j.ijrobp.2003.09.004
- Blanchard P, Baujat B, Holostenco V, Bourredjem A, Baey C, Bourhis J, et al; MACH-CH Collaborative group. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): a comprehensive analysis by tumour site. Radiother Oncol 2011; 100: 33-40. doi: 10.1016/j.radonc.2011.05.036
- Bisdas S, Rumboldt Z, Surlan-Popovic K, Baghi M, Koh TS, Vogl TJ, et al. Perfusion CT in squamous cell carcinoma of the upper aerodigestive tract: long-term predictive value of baseline perfusion CT measurements. AJNR Am J Neuroradiol 2010; 31: 576-81. doi: 10.3174/ajnr.A1852
- Surlan-Popovic, K. Bisdas S, Rumboldt Z, Koh TS, Strojan P. Changes in perfusion CT of advanced squamous cell carcinoma of the head and neck treated during the course of concomitant chemoradiotherapy. Am J Neuroradiol 2010; 31: 570-5. doi: 10.3174/ajnr.A1859
- Pietsch C, de Galiza Barbosa F, Hullner MW, Schmid DT, Haerle SK, Huber GF, et al. Combined PET/CT-perfusion in patients with head and neck cancers might predict failure after radio-chemotherapy: a proof of concept study. BMC Med Imaging 2015; 15: 60. doi: 10.1186/s12880-015-0102-z
- Koh D-M, Lee J-M, Bittencourt LK, Blackledge M, Collins DJ. Body diffusion-weighted MR imaging in oncology. Magn Reson Imaging Clin N Am 2016; 24: 31-44. doi: 10.1016/j.mric.2015.08.007
- Gaddikeri S, Gaddikeri RS, Tailor T, Anzai Y. Dynamic contrast-enhanced MR imaging in head and neck cancer: techniques and clinical applications. AJNR Am J Neuroradiol 2016; 37: 588-95. doi: 10.3174/ajnr.A4458
- Kim H, Hartman YE, Zhai G, Chung TK, Korb ML, Beasley TM, et al. Dynamic contrast-enhanced MRI evaluates the early response of human head and neck tumor xenografts following anti-EMMPRIN therapy with cisplatin or irradiation. J Magn Reson Imaging 2015; 42: 936-45. doi: 10.1002/jmri.24871
- Cao Y, Popovtzer A, Li D, Chepeha DB, Moyer JS, Prince ME, et al. Early prediction of outcome in advanced head-and-neck cancer based on tumor blood volume alterations during therapy: a prospective study. Int J Radiat Oncol Biol Phys 2008; 72: 1287-90. doi: 10.1016/j.ijrobp.2008.08.024.EARLY
- Baer AH, Hoff BA, Srinivasan A, Galbán CJ, and Mukherji SK. Feasibility analysis of the parametric response map as an early predictor of treatment efficacy in head and neck cancer. AJNR Am J Neuroradiol 2015; 36: 757-62. doi: 10.3174/ajnr.A4296
- Strojan P, Zadnik V, Šifrer R, Lanišnik B, Didanović V, Jereb S, et al. Incidence trends in head and neck squamous cell carcinoma in Slovenia, 1983–2009: role of human papillomavirus infection. Eur Arch Otorhinolaryngol 2015; 272: 3805-14. doi: 10.1007/s00405-014-3459-7
- Tofts PS, Brix G, Buckley DL, Evelhoch JL, Henderson E, Knopp MV, et al. Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols. J Magn Reson Imaging 1999; 10: 223-32. doi: 10.1002/(SICI)1522-2586(199909)10:3<;223::AID-JMRI2>3.0.CO;2-S
- Schwartz DL, Garden AS, Thomas J, Chen Y, Zhang Y, Lewin J, et al. Adaptive radiotherapy for head-and-neck cancer: initial clinical outcomes from a prospective trial. Int J Radiat Oncol Biol Phys 2012; 83: 986-93. doi: 10.1016/j. ijrobp.2011.08.017
- Yuan J, Lo G, King AD. Functional magnetic resonance imaging techniques and their development for radiation therapy planning and monitoring in the head and neck cancers. Quant Imaging Med Surg 2016; 6: 430-48. doi: 10.21037/qims.2016.06.11
- Kim S, Loevner LA, Quon H, Kilger A, Sherman E, Weinstein G, et al. Prediction of response to chemoradiation therapy in squamous cell carcinomas of the head and neck using dynamic contrast-enhanced MR imaging. AJNR Am J Neuroradiol 2010; 31: 262-8. doi: 10.3174/ajnr.A1817
- Chawla S, Kim S, Loevner LA, Hwang WT, Weinstein G, Chalian A, et al. Prediction of disease-free survival in patients with squamous cell carcinomas of the head and neck using dynamic contrast-enhanced MR imaging. AJNR Am J Neuroradiol 2011; 32: 778-84. doi: 10.3174/ajnr.A2376
- Chawla S, Kim S, Dougherty L, Wang S, Loevner LA, Quon H, et al. Pretreatment diffusion-weighted and dynamic contrast-enhanced MRI for prediction of local treatment response in squamous cell carcinomas of the head and neck. Am J Roentgenol 2013; 200: 35-43. doi: 10.2214/AJR.12.9432
- Chikui T, Kitamoto E, Kawano S, Sugiura T, Obara M, Simonetti AW, et al. Pharmacokinetic analysis based on dynamic contrast-enhanced MRI for evaluating tumor response to preoperative therapy for oral cancer. J Magn Reson Imaging 2012; 36: 589-97. doi: 10.1002/jmri.23704
- Ng SH, Lin CY, Chan SC, Yen TC, Liao CT, Chang JT, et al. Dynamic contrast-enhanced MR imaging predicts local control in oropharyngeal or hypopharyngeal squamous cell carcinoma treated with chemoradiotherapy. PLoS One 2013; 8: 1-11. doi: 10.1371/journal.pone.0072230
- Ng SH, Lin CY, Chan SC, Lin YC, Yen TC, Liao CT, et al. Clinical utility of multimodality imaging with dynamic contrast-enhanced MRI, diffusion-weighted MRI, and18F-FDG PET/ CT for the prediction of neck control in oropharyngeal or hypopharyngeal squamous cell carcinoma treated with chemoradiation. PLoS One 2014; 9: 1-19. doi: 10.1371/journal.pone.0115933
- Chan SC, Cheng NM, Hsieh CH, et al. Multiparametric imaging using 18F-FDG PET/CT heterogeneity parameters and functional MRI techniques: prognostic significance in patients with primary advanced oropharyngeal or hypopharyngeal squamous cell carcinoma treated with chemoradiotherapy. Oncotarget 2017; 8: 62606-21. doi: 10.18632/oncotarget.15904
- Surov A, Meyer HJ, Leifels L, Höhn A-K, Richter C, Winter K. Histogram analysis parameters of dynamic contrast-enhanced magnetic resonance imaging can predict histopathological findings including proliferation potential, cellularity, and nucleic areas in head and neck squamous cell carcinoma. Oncotarget 2018; 9: 21070-7. doi: 10.18632/oncotarget.24920
- Kim SH, Lee HS, Kang BJ, Song BJ, Kim HB, Lee H, et al. Dynamic contrast-enhanced MRI perfusion parameters as imaging biomarkers of angiogenesis. PLoS One 2016; 11: 1-12. doi: 10.1371/journal.pone.0168632
- Choi YJ, Lee JH, Kim HO, Kim DY, Yoon RG, Cho SH, et al. Histogram analysis of apparent diffusion coefficients for occult tonsil cancer in patients with cervical nodal metastasis from an unknown primary site at presentation. Radiology 2016; 278: 146-55. doi: 10.1148/radiol.2015141727
- García-Figueiras R, Padhani AR, Beer AJ, Baleato-González S, Vilanova JC, Luna A, et al. Imaging of tumor angiogenesis for radiologists - part 1: biological and technical basis. Curr Probl Diagn Radiol 2015; 44: 407-24. doi: 10.1067/j.cpradiol.2015.02.010
- Manoochehri Khoshinani H, Afshar S, Najafi R. Hypoxia: a double-edged sword in cancer therapy. Cancer Invest 2016; 34: 536-45. doi: 10.1080/07357907.2016.1245317
- Ng SH, Liao CT, Lin CY, Chan SC, Lin YC, Yen TC, et al. Dynamic contrast-enhanced MRI, diffusion-weighted MRI and 18F-FDG PET/CT for the prediction of survival in oropharyngeal or hypopharyngeal squamous cell carcinoma treatedwithchemoradiation. Eur Radiol 2016; 26: 4162-72. doi: 10.1007/s00330-016-4276-8
- Preda L, Conte G, Bonello L, Giannitto C, Travaini LL, Raimondi S, et al. Combining standardized uptake value of FDG-PET and apparent diffusion coefficient of DW-MRI improves risk stratification in head and neck squamous cell carcinoma. Eur Radiol 2016; 26: 4432-41. doi: 10.1007/s00330-016-4284-8
- Noij DP, de Jong MC, Mulders LG, Marcus JT, de Bree R, Lavini C, et al. Contrast-enhanced perfusion magnetic resonance imaging for head and neck squamous cell carcinoma: a systematic review. Oral Oncol 2015; 51: 124-38. doi: 10.1016/j.oraloncology.2014.10.016
- Driessen JP, Caldas-Magalhaes J, Janssen LM, et al. Diffusion-weighted MR imaging in laryngeal and hypopharyngeal carcinoma: association between apparent diffusion coefficient and histologic findings. Radiology 2014; 272: 456-63. doi: 10.1148/radiol.14131173
- Kolenda T, Przybyła W, Kapałczyńska M, Teresiak A, Zajączkowska M, Bliźniak R, et al. Tumor microenvironment - unknown niche with powerful therapeutic potential. Rep Pract Oncol Radiother 2018; 23: 143-53. doi: 10.1016/j. rpor.2018.01.004
- Choi HS, Kim AH, Ahn SS, Shin NY, Kim J, Lee SK. Glioma grading capability: comparisons among parameters from dynamic contrast-enhanced MRI and ADC value on DWI. Korean J Radiol 2013; 14: 487-92. doi: 10.3348/kjr.2013.14.3.487
- Rata M, Collins DJ, Darcy J, Messiou C, Tunariu N, Desouza N, et al. Assessment of repeatability and treatment response in early phase clinical trials using DCE-MRI: comparison of parametric analysis using MR- and CT-derived arterial input functions. Eur Radiol 2016; 26: 1991-1998. doi: 10.1007/s00330-015-4012-9